35 results
8-K
EX-10.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;
(f)the future value … payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;
(f) the future value of the Shares underlying
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
/retirement benefits, will be provided by or paid for by the Company. Notwithstanding the foregoing, during the Employment Term, the Company will pay
8-K
EX-99.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
as Athira’s Chief Medical Officer and congratulate him on his retirement. In addition to his five years with Athira, Hans has more than 30 years
8-K
EX-10.3
ATHA
Athira Pharma Inc
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the Worker
8-K
EX-10.2
v1zsal
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
j3x8h
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-99.1
pdo30oz8psj 9jl
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.1
3ygl lj8nxcdg74
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
S-3
EX-4.3
q391g4x9wx
15 Nov 21
Shelf registration
4:06pm
8-K
EX-10.1
4kv19e b4nvlk25ok1fh
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
10-K
xt6gukj4
25 Mar 21
Annual report
12:00am
424B4
lrrdj lyth8q
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
uo74chyldh xg
6 Jan 21
Draft registration statement
12:00am
424B4
pi2k6ws6uovug7qeu8
18 Sep 20
Prospectus supplement with pricing info
4:05pm